MPO KO mice are resistant to the neuronal cell dysfunction typically observed in murine models of ischemic stroke, and inhibition of MPO with 4-aminobenzoic acid hydrazide (ABAH) protects from tissue damage, suggesting that MPO is a realistic target for therapeutics to mitigate the inflammation associated with brain trauma [108]. The gene discussed is MPO; the disease is brain injury.